Treating acute cystitis with biodegradable micelle-encapsulated quercetin

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 2239-2247

  Wang, Bi Lan ^a   Gao, Xiang ^a,b   Men, Ke ^a   Qiu, Jinfeng ^a   Yang, Bowen ^c   Gou, Ma Ling ^a   Huang, Mei Juan ^a   Huang, Ning ^b   Qian, Zhi Yong ^a   Zhao, Xia ^a   Wei, Yu Quan ^a  

^a SICHUAN UNIVERSITY   (China)

^b Medical Sciences   (China)

^c SICHUAN UNIVERSITY   (China)

Author keywords

MPEG PCL; Nanomedicine; Self assembly

Indexed keywords

QUERCETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CYSTITIS; CYTOTOXICITY TEST; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFECT; DRUG FORMULATION; DRUG SCREENING; DRUG SOLUBILITY; DRUG STRUCTURE; EDEMA; FEMALE; IN VIVO STUDY; INFLAMMATORY CELL; MICELLE; MOUSE; NANOENCAPSULATION; NANOPHARMACEUTICS; NONHUMAN; PARTICLE SIZE; TIMED DRUG RELEASE; TISSUE DISTRIBUTION;

ACUTE DISEASE; ANALYSIS OF VARIANCE; ANIMALS; CYSTITIS; DISEASE MODELS, ANIMAL; FEMALE; HISTOCYTOCHEMISTRY; MICE; MICE, INBRED BALB C; MICELLES; NANOCAPSULES; ORGAN SIZE; PARTICLE SIZE; POLYESTERS; POLYETHYLENE GLYCOLS; QUERCETIN; TISSUE DISTRIBUTION; URINARY BLADDER;

ESCHERICHIA COLI;

EID: 84870323795     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S29416     Document Type: Article

References (33)

1. Foxman B. The epidemiology of urinary tract infection. Nat Rev Urol. 2010;7:653-660.
2. O'Neill LA. Bacteria fight back against Toll-like receptors. Nat Med. 2008;14:370-372.
3. Daniels IR, Zaman SR. Increasing prevalence of antimicrobial resistance among uropathogens. JAMA. 1999;282(4):325-326.
4. Stamm WE, Hooton TM. Management of urinary tract infections in adults. N Engl J Med. 1993;329:1328-1334.
5. Ferry S, Burman LG, Holm SE. Clinical and bacteriological effects of therapy of urinary tract infection in primary health care: relation to in vitro sensitivity testing. Scand J Infect Dis. 1988;20:535-544.
6. Septimus EJ, Kuper KM. Clinical challenges in addressing resistance to antimicrobial drugs in the twenty-first century. Clin Pharmacol Ther. 2009;86:336-339.
7. Evans RJ. Intravesical therapy for overactive bladder. Curr Urol Rep. 2005;6:429-433.
8. Buyse G, Waldeck K, Verpoorten C, Björk H, Casaer P, Andersson KE. Intravesical oxybutynin for neurogenic bladder dysfunction: less systemic side effects due to reduced first pass metabolism. J Urol. 1998;160:892-896.
9. Walker MC, Masters JR, Parris CN, Hepburn PJ, English PJ. Intravesical chemotherapy: in vitro studies on the relationship between dose and cytotoxicity. Urol Res. 1986;14(3):137-140.
10. Lee H, Cima MJ. An intravesical device for the sustained delivery of lidocaine to the bladder. J Control Release. 2011;149:133-139.
11. Manthey JA. Biological properties of flavonoids pertaining to inflammation. Microcirculation. 2000;7:29-34.
12. Moskaug JØ, Carlsen H, Myhrstad M, Blomhoff R. Molecular imaging of the biological effects of quercetin and quercetin-rich foods. Mech Ageing Dev. 2004;125:315-324.
13. Ohnishi E, Bannai H. Quercetin potentiates TNF-induced antiviral activity. Antiviral Res. 1993;22(4):327-331.
14. Boots AW, Wilms LC, Swennen EL, Kleinjans JC, Bast A, Haenen GR. In vitro and ex vivo anti-inflammatory activity of quercetin in healthy volunteers. Nutrition. 2008;24(7-8):703-710.
15. Miean KH, Mohamed S. Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants. J Agric Food Chem. 2001;49:3106-3112.
16. Wei YQ, Zhao X, Kariya Y, Fukata H, Teshigawara K, Uchida A. Induction of apoptosis by quercetin: involvement of heat shock protein. Cancer Res. 1994;54:4952-4957.
17. Cheng S, Gao N, Zhang Z, et al. Quercetin induces tumor-selective apoptosis through downregulation of Mcl-1 and activation of Bax. Clin Cancer Res. 2010;16:5679-5691.
18. García-Mediavilla V, Crespo I, Collado PS, et al. The anti-inflammatory flavones quercetin and kaempferol cause inhibition of inducible nitric oxide synthase, cyclooxygenase-2 and reactive C-protein, and downregulation of the nuclear factor kappaB pathway in Chang Liver cells. Eur J Pharmacol. 2007;557(2-3):221-229.
19. Hämäläinen M, Nieminen R, Vuorela P, Heinonen M, Moilanen E. Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-B activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-B activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators Inflamm. 2007;2007:45673.
20. Katske F, Shoskes DA, Sender M, Poliakin R, Gagliano K, Rajfer J. Treatment of interstitial cystitis with a quercetin supplement. Tech Urol. 2001;7(1):44-46.
21. Zhang L, Chan JM, Gu FX, et al. self-assembled lipid2polymer hybrid nanoparticles: a robust drug delivery platform. ACS Nano. 2008;2:1696-1702.
22. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2007;2(12):751-760.
23. Shutava TG, Balkundi SS, Vangala P, et al. Layer-by-layer-coated gelatin nanoparticles as a vehicle for delivery of natural polyphenols. ACS Nano. 2009;3:1877-1885.
24. Shieh YA, Yang SJ, Wei MF, Shieh MJ. Aptamer-based tumortargeted drug delivery for photodynamic therapy. ACS Nano. 2010;4:1433-1442.
25. Wang T, He N. Preparation, characterization and applications of lowmolecular-weight alginate-oligochitosan nanocapsules. Nanoscale. 2010;2:230-239.
26. Zhou S, Deng X, Yang H. Biodegradable poly (2-caprolactone)-poly (ethylene glycol) block copolymers: characterization and their use as drug carriers for a controlled delivery system. Biomaterials. 2003;24:3563-3570.
27. Gou M, Wei X, Men K, et al. PCL/PEG copolymeric nanoparticles: potential nanoplatforms for anticancer agent delivery. Curr Drug Targets. 2011;12:1131-1150.
28. Gou M, Men K, Shi H, et al. Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo. Nanoscale. 2011;3:1558-1567.
29. Mulvey MA, Lopez-Boado YS, Wilson CL, et al. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science. 1998;282:1494-1497.
30. Flores-Carreras O, Martínez-Espinoza CJ, González-Ruiz MI. Experience in the treatment of interstitial cystitis: review of 17 cases. Ginecol Obstet Mex. 2011;79(3):125-130.
31. Overman A, Chuang CC, McIntosh M. Quercetin attenuates inflammation in human macrophages and adipocytes exposed to macrophageconditioned media. Int J Obes (Lond). 2011;35:1165-1172.
32. Yuan ZP, Chen LJ, Fan LY, et al. Liposomal quercetin efficiently suppresses growth of solid tumors in murine models. Clin Cancer Res. 2006;12(10):3193-3199.
33. Gou M, Zheng X, Men K, et al. Self-assembled hydrophobic honokiol loaded MPEG-PCL diblock copolymer micelles. Pharm Res. 2009;26(9):2164-2173.